China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Recent federal actions could derail decades of progress. Meanwhile China has prioritized investment in biotech.

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

This is where Hong Kong's unique identity shines. As both part of China and a globally connected offshore market, it occupies ...

The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...

Discover how U.S. biotechs can learn from China's success in affordable, high-quality drug development. Read more here.